Baqsimi is a nasal spray formulation of glucagon, already widely used as an injectable treatment for hypoglycaemia, which can occur when people with diabetes inadvertently take too much insulin.

Amphastar Pharmaceuticals (NASDAQ:AMPH – Get Free Report) and UroGen Pharma (NASDAQ:URGN – Get Free Report) are both medical companies, but which is the superior business? We will contrast the two ...

Here’s what you need to know about nasal spray dependency, the symptoms to watch out for, and how to manage withdrawal. When congestion sets in, the cause is typically inflammation in the nasal ...

An alternative, nasal spray, formulation has been developed that demonstrates good efficacy, high tolerability and a very fast onset of action. This study assessed the pharmacokinetics and ...

Nasacort 24HR Allergy Nasal Spray is the first product Dr. Randolph Betts, MD, a family medicine practitioner based in California, recommends for nasal congestion. He notes that almost all his ...

But there’s a brand new medicine available for that. It’s called Timolol nasal spray and was developed in Kansas City. Doctors at North Kansas City Hospital found the same liquid in Timolol ...

Eli Lilly's nasal spray Baqsimi was also approved in 2019 for a similar indication. "We at Zealand Pharma are acutely aware of the significant unmet medical need for newborns and children with ...

Los Angeles Capital Management LLC purchased a new position in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Free ...

After hours: November 29 at 3:37 PM EST Loading Chart for AMPH ...

Amanda Gardner is a freelance health reporter whose stories have appeared in cnn.com, health.com, cnn.com, WebMD, HealthDay, Self Magazine, the New York Daily News, Teachers & Writers Magazine ...